Targeting the Immune-Neurovascular Interface to Ameliorate Pericyte Dysfunction with a Multifunctional Peptide-Drug Conjugate Nanoprodrug for Multiple Sclerosis Therapy
ACS nano · 2026 Oct 27 · Mu Y, Wen K, Zhou L et
PR
By Priya Raman · Science Reporter
Oct 26 20:00 ETSource: ACS nano
From the source
Read at pubmed.ncbi.nlm.nih.govTargeting the Immune-Neurovascular Interface to Ameliorate Pericyte Dysfunction with a Multifunctional Peptide-Drug Conjugate Nanoprodrug for Multiple Sclerosis Therapy
ACS nano · 2026 Oct 27 · Mu Y, Wen K, Zhou L et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42937574/
